| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cullinan Therapeutics, Inc. (CGEM) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. CGEM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.96M | $134.72M | - | |
| CEO | 420.7K | $6.32M | - | |
| Other | 169.5K | $2.55M | - | |
| Other | 135.4K | $2.04M | - | |
| Other | 132.6K | $1.99M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2021 | Hughes Owen70 | President And CEO | Buy | 2,500 | $21.00 | $52,500.00 | +0.5% | |
| Jan 12, 2021 | Trigilio Jeffrey51 | Chief Financial Officer | Buy | 2,250 | $21.00 | $47,250.00 | New |